Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China · Delayed Price · Currency is CNY 30.55
-1.70 (-5.27%)
May 21, 2026, 3:04 PM CST
SHE:301130 Revenue
In the year 2025, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had annual revenue of 234.84M CNY, down -8.41%. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had revenue of 55.93M in the quarter ending March 31, 2026, with 7.10% growth.
Revenue
234.84M
Revenue Growth
-8.41%
P/S Ratio
9.82
Revenue / Employee
733.88K
Employees
320
Market Cap
2.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 234.84M | -21.56M | -8.41% |
| Dec 31, 2024 | 256.41M | 30.91M | 13.71% |
| Dec 31, 2023 | 225.49M | -29.98M | -11.73% |
| Jan 1, 2023 | 255.47M | -30.19M | -10.57% |
| Jan 1, 2022 | 285.66M | -662.79K | -0.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 3.86B |
| Enwei Pharmaceutical | 879.60M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 843.87M |
| Ginwa Enterprise (Group) | 563.66M |
| Chengdu huasun technology group Inc. , LTD. | 527.86M |
| Zhejiang Shapuaisi Pharmaceutical | 459.57M |
| Anhui Huangshan Capsule | 437.17M |
| Guhan Pharmaceutical Group | 344.12M |